Pillar Invest Corp 3

3 · Aceragen, Inc. · Filed Jun 23, 2023

Form 3

Period: 2023-05-16

Director10% Owner

Holdings

Common Stock
(indirect: By Abude Umari)
170,712
Warrants
(indirect: By Pillar Pharmaceuticals 6, L.P.)
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (45,114 underlying)
Common Stock
(indirect: By Youssef El Zein)
1,547
Common Stock
(indirect: By Foundation)
355,247
Common Stock
(indirect: By Pillar Pharmaceuticals 6, L.P)
135,540
Warrants
(indirect: By Foundation)
Exercise: $0.01From: 2020-07-13Exp: 2023-07-13→ Common Stock (162,601 underlying)
Warrants
(indirect: By Foundation)
Exercise: $0.01From: 2020-12-11Exp: 2023-12-11→ Common Stock (35,687 underlying)

Footnotes (2)

[F1]Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
[F2]The warrants are exercisable subject to a beneficial ownership blocker provision that prevents the holder from exercising the warrants if such exercise would result in the holder beneficially owning more than 19.99% of the Issuer's Common Stock outstanding following such exercise.

Documents

1 file